Advantages and disadvantages of GH/IGF-I combination treatment

Reviews in Endocrine and Metabolic Disorders

Volumn 10, Issue 2, 2009, Pages 157-162

  Janssen, J A M J L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Combination therapy; GH deficiency; Growth hormone; Insulin like growth factor I

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTHRALGIA; BREAST CANCER; COLORECTAL CANCER; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; FATIGUE; GLUCOSE METABOLISM; HEADACHE; HUMAN; INFECTION; LARON SYNDROME; MYALGIA; OPTIC NEURITIS; PAROTITIS; PERIPHERAL EDEMA; PROSTATE CANCER; REVIEW; SEPTIC SHOCK; TRAUMATIC BRAIN INJURY;

CARBOHYDRATE METABOLISM; DRUG SYNERGISM; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I;

EID: 67349149713     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-008-9081-5     Document Type: Review

References (36)

1. Blum WF. Chapter 3: Insulin-like growth factors and IGF-binding proteins: their use for diagnosis of growth hormone deficiency. In: Juul A, Jorgensen JOL, editors. Growth hormone in adults. Cambridge: Cambridge University Press; 1996. p. 48-74.
2. JM Ketelslegers D Maiter M Maes LE Underwood JP Thissen 1995 Nutritional regulation of insulin-like growth factor-I Metabolism 44 Suppl 4(10) 50 7
3. JL Liu S Yakar D LeRoith 2000 Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system Proc Soc Exp Biol Med 223 344 51 (Pubitemid 30180781)
4. MA Hussain O Schmitz ER Froesch 1995 Growth hormone, insulin, and insulin-like growth factor I: revisiting the food and famine theory News Physiol Sci 10 81 6
5. CA Bondy LE Underwood DR Clemmons HP Guler MA Bach M Skarulis 1994 Clinical uses of insulin-like growth factor I Ann Intern Med 120 593 601 (Pubitemid 24091602)
6. SA Kaplan P Cohen 2007 The somatomedin hypothesis 2007: 50 years later J Clin Endocrinol Metab 92 4529 35 (Pubitemid 350223421)
7. D Le Roith C Bondy S Yakar JL Liu A Butler 2001 The somatomedin hypothesis: 2001 Endocr Rev 22 53 74 (Pubitemid 32187803)
8. DR Clemmons 2007 Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer Nat Rev Drug Discov 6 821 33 (Pubitemid 47500506)
9. S Rajaram DJ Baylink S Mohan 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions Endocr Rev 18 801 31 (Pubitemid 28009568)
10. RC Baxter 1994 Insulin-like growth factor binding proteins in the human circulation: a review Horm Res 42 140 4 (Pubitemid 24336141)
11. CY Lee MM Rechler 1995 Formation of 150-kDa binary complexes of insulin-like growth factor binding protein-3 and the acid-labile subunit in vitro and in vivo Prog Growth Factor Res 6 241 51
12. PF Collett-Solberg P Cohen 1996 The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action Endocrinol Metab Clin North Am 25 591 614 (Pubitemid 26304475)
13. JI Jones DR Clemmons 1995 Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 3 34
14. C Duan Q Xu 2005 Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions Gen Comp Endocrinol 142 44 52 (Pubitemid 40614693)
15. RC Jenkins RJ Ross 1996 Growth hormone therapy for protein catabolism Q J Med 89 813 9 (Pubitemid 26382112)
16. MM Rechler DR Clemmons 1998 Regulatory actions of insulin-like growth factor binding proteins Trends Endocrinol Metab 9 176 83 (Pubitemid 28328220)
17. Botfield C, Hinds CJ. Growth hormone and IGF-I as anabolic therapy. In: Jenkins RC, Ross RJM, editors. The endocrine response to acute illness. Front Horm Res. vol 24. Basel: Karger; 1999. p. 176-200.
18. SR Kupfer LE Underwood RC Baxter DR Clemmons 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously J Clin Invest 91 391 6 (Pubitemid 23064118)
19. Z Laron 2004 Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003 J Clin Endocrinol Metab 89 1031 44 (Pubitemid 38368385)
20. Rosenbloom AL, Connor EL. Chapter 3: Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis. In: Lifshitz F, editor. Pediatric endocrinology. 5th ed. New York: Informa Healthcare; 2007. p. 65-99.
21. A Grahnén K Kastrup U Heinrich M Gourmelen MA Preece MA Vaccarello 1993 Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency Acta Paediatr Suppl 82 Suppl 391 9 13 (Pubitemid 23293838)
22. Rosenbloom AL. IGF-I treatment of growth hormone sensitivity. In: Rosenfeld RG, Roberts CT, editors. The IGF system: molecular biology, physiology, and clinical applications. Towata, New Jersey: Humana; 1999. p. 739-69.
23. J Hatton R Kryscio M Ryan L Ott B Young 2006 Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury J Neurosurg 105 843 52
24. DR Clemmons LE Underwood 1994 Clinical review 59: uses of human insulin-like growth factor-I in clinical conditions J Clin Endocrinol Metab 79 4 6 (Pubitemid 2118565)
25. K Berneis M Oehri M Kraenzlin U Keller 1999 Effects of IGF-I combined with GH on glucocorticoid-induced changes of bone and connective tissue turnover in man J Endocrinol 162 259 64 (Pubitemid 29369173)
26. SJ Hazel CM Gillespie RJ Moore RG Clark KF Jureidini AA Martin 1994 Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination Kidney Int 46 58 68 (Pubitemid 24210436)
27. BY Nguyen M Clerici DJ Venzon S Bauza WJ Murphy DL Longo 1998 Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients AIDS 12 895 904 (Pubitemid 28241403)
28. WH Daughaday P Rotwein 1989 Insulin-like growth factors I and II: peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations Endocr Rev 10 68 91 (Pubitemid 19156368)
29. A Sandra M Boes BL Dake JB Stokes RS Bar 1998 Infused IGF-I/IGFBP-3 complex causes glomerular localization of IGF-I in the rat kidney Am J Physiol 275 E32 7 (Pubitemid 28374648)
30. A Cittadini H Strömer SE Katz R Clark AC Moses JP Morgan 1996 Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation Circulation 93 800 9 (Pubitemid 26052467)
31. JM Chan MJ Stampfer E Giovannucci PH Gann J Ma P Wilkinson 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 563 6 (Pubitemid 28067285)
32. SE Hankinson WC Willett GA Colditz DJ Hunter DS Michaud B Deroo 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer Lancet 351 1393 6 (Pubitemid 28209997)
33. J Ma MN Pollak E Giovannucci JM Chan Y Tao CH Hennekens 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 J Natl Cancer Inst 91 620 5 (Pubitemid 29194048)
34. MO Savage C Camacho-Hübner DB Dunger 2004 Therapeutic applications of the insulin-like growth factors Growth Horm IGF Res 14 301 8 (Pubitemid 38878056)
35. PD Lee JM Pivarnik JG Bukar N Muurahainen PS Berry PR Skolnik 1996 A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection J Clin Endocrinol Metab 81 2968 75 (Pubitemid 26323894)
36. MA Hussain O Schmitz A Mengel Y Glatz JS Christiansen J Zapf 1994 Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans J Clin Invest 94 1126 33 (Pubitemid 24286454)